20082025

Research activity per year

Fingerprint

Dive into the research topics where Amy DeZern is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • Advancing drug development in myelodysplastic syndromes

    Mina, A., McGraw, K. L., Cunningham, L., Kim, N., Jen, E. Y., Calvo, K. R., Ehrlich, L. A., Aplan, P. D., Garcia-Manero, G., Foran, J. M., Garcia, J. S., Zeidan, A. M., DeZern, A. E., Komrokji, R., Sekeres, M. A., Scott, B., Buckstein, R., Tinsley-Vance, S., Verma, A. & Wroblewski, T. & 2 others, Pavletic, S. & Norsworthy, K., Mar 11 2025, In: Blood Advances. 9, 5, p. 1095-1104 10 p.

    Research output: Contribution to journalReview articlepeer-review

  • A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML

    Garcia-Manero, G., McCloskey, J., Griffiths, E. A., Yee, K. W. L., Zeidan, A. M., Al-Kali, A., Deeg, H. J., Sabloff, M., Keating, M. M., Zhu, N., Gabrail, N. Y., Fazal, S., Maly, J., Odenike, O., DeZern, A. E., O’Connell, C. L., Roboz, G. J., Busque, L., Buckstein, R. & Amin, H. & 6 others, Leber, B., Shastri, A., Oganesian, A., Keer, H. N., Azab, M. & Savona, M. R., 2025, In: Future Oncology. 21, 8, p. 929-941 13 p.

    Research output: Contribution to journalArticlepeer-review

  • Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT

    Gurnari, C., Robin, M., Adès, L., Aljurf, M., Almeida, A., Duarte, F. B., Bernard, E., Cutler, C., Della Porta, M. G., De Witte, T., DeZern, A., Drozd-Sokolowska, J., Duncavage, E., Fenaux, P., Gagelmann, N., Garcia-Manero, G., Haferlach, C., Haferlach, T., Hasserjian, R. & Hellström-Lindberg, E. & 25 others, Jacoby, M., Kulasekararaj, A., Lindsley, R. C., Maciejewski, J. P., Makishima, H., Malcovati, L., Mittelman, M., Myhre, A. E., Ogawa, S., Onida, F., Papaemmanuil, E., Passweg, J., Platzbecker, U., Pleyer, L., Raj, K., Santini, V., Sureda, A., Tobiasson, M., Voso, M. T., Yakoub-Agha, I., Zeidan, A., Walter, M., Kröger, N., McLornan, D. P. & Cazzola, M., May 1 2025, In: Blood. 145, 18, p. 1987-2001 15 p.

    Research output: Contribution to journalComment/debatepeer-review

  • Imetelstat: a new addition to the therapeutic landscape of lower-risk MDS

    Abaza, Y. & DeZern, A. E., Jan 30 2025, In: Blood. 145, 5, p. 469-474 6 p.

    Research output: Contribution to journalReview articlepeer-review

  • Myelodysplastic Syndromes, Version 2.2025 Featured Updates to the NCCN Guidelines

    Greenberg, P. L., Stone, R. M., Abaza, Y., Al-Kali, A., Anand, S., Ball, B., Bennett, J. M., Borate, U., Brunner, A. M., Chai-Ho, W., Curtin, P., DeZern, A. E., Gaensler, K., Gahvari, Z., Garcia-Manero, G., Griffiths, E. A., Haque, T., Jacoby, M., Jonas, B. A. & Keel, S. & 18 others, Khanal, R., Kishtagari, A., Madanat, Y., Maness, L. J., McCurdy, S. R., McMahon, C., Odenike, O., Osman, A., Reddy, V. V., Sallman, D. A., Sayar, H., Shallis, R., Singh, A., Tanaka, T., Thota, S., Kovach, E., Nguyen, J. & Hochstetler, C., Mar 2025, In: JNCCN Journal of the National Comprehensive Cancer Network. 23, 3, p. 66-75 10 p.

    Research output: Contribution to journalArticlepeer-review